FOXO3 and ovarian cancer: Tumor-associated macrophage (TAM)-derived EVs carry miR-29a-3p, which targets forkhead box O3 (FOXO3) and leads to increased programmed death-ligand 1 (PD-L1) expression in ovarian cancer cells.